Advanced Solid Tumor Clinical Trials in Newport Beach, California
5 studies are recruiting for advanced solid tumor in Newport Beach, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of KK2269 in Adult Participants With Solid Tumors
This is a first-in-human study of KK2269. Part 1 and Part 2 will be conducted as a multicenter, open-label, non-randomized, dose-escalation study. Participants with advanced or metastatic solid tumors for which no standard therapy is available will be enrolled in Part 1. In Part 1, the primary obje…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Hoag Memorial Hospital Presbyterian, Newport Beach, California
- Locations
- 32 in total
- Run by
- Kyowa Kirin Co., Ltd.
-
SLV-154 Treatment of Advanced Cancers
This is a Phase 1 study comprising a Phase 1a dose-escalation portion and a Phase 1b expansion portion evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with advanced solid tumors.
- Stage
- Phase 1
- Ages
- 12 and older
- Site
- Hoag Memorial Hospital Presbyterian, Newport Beach, California
- Locations
- 10 in total
- Run by
- Solve Therapeutics
-
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
This is a phase 1/2, multicenter, open-label study. The phase 1 portion is a dose escalation and expansion study of STK-012 as monotherapy and in combination therapy in patients with selected advanced solid tumors. The phase 2 portion is a randomized study of STK-012 in combination with standard of…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Hoag Memorial Hospital Presbyterian, Newport Beach, California
- Locations
- 47 in total
- Run by
- Synthekine
-
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
The purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Hoag Memorial Hospital Presbyterian, Newport Beach, California
- Locations
- 21 in total
- Run by
- Bristol-Myers Squibb
-
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Hoag Memorial Hospital, Newport Beach, California
- Locations
- 14 in total
- Run by
- Volastra Therapeutics, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.